Skip to main content
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · IEX Real-Time Price · USD
9.52
-0.17 (-1.75%)
At close: Apr 17, 2024, 4:00 PM
9.35
-0.17 (-1.79%)
After-hours: Apr 17, 2024, 4:06 PM EDT

Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of $458.53 million as of April 17, 2024. Its market cap has decreased by -35.91% in one year.

Market Cap
458.53M
Enterprise Value
404.42M
1-Year Change
-35.91%
Ranking
#2997
Category
Small-Cap
Stock Price
$9.52

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $458.53M, a decrease of -38.10%. That is a compound annual growth rate of -4.72%.

History

DateMarket Cap% Change
Apr 17, 2024458.50M-1.76%
Apr 16, 2024466.70M-2.32%
Apr 15, 2024477.80M3.22%
Apr 12, 2024462.90M7.63%
Apr 11, 2024430.10M-6.40%
Apr 10, 2024459.50M0.64%
Apr 9, 2024456.60M0.11%
Apr 8, 2024456.10M1.72%
Apr 5, 2024448.40M1.86%
Apr 4, 2024440.20M-1.63%
Apr 3, 2024447.50M2.10%
Apr 2, 2024438.30M0.78%
Apr 1, 2024434.90M0.67%
Mar 28, 2024432.00M-0.46%
Mar 27, 2024434.00M2.17%
Mar 26, 2024424.80M0.69%
Mar 25, 2024421.90M-1.79%
Mar 22, 2024429.60M-0.46%
Mar 21, 2024431.60M-0.55%
Mar 20, 2024434.00M1.81%
Mar 19, 2024426.30M2.33%
Mar 18, 2024416.60M0.12%
Mar 15, 2024416.10M0.34%
Mar 14, 2024414.70M-2.15%
Mar 13, 2024423.80M3.27%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
MultiPlan 475.62M
C4 Therapeutics 471.29M
PetIQ 464.96M
Third Harmonic Bio 459.26M
Editas Medicine 458.98M
Taysha Gene Therapies 458.19M
Travere Therapeutics 455.83M
LENZ Therapeutics 451.94M
Market Cap Rankings